Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19
Clinical trial NCT04884295 · TERMINATED
Trial details
- NCT number
- NCT04884295
- Sponsor
- ExeVir Bio BV
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-26
- Primary completion
- 2022-03-18
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.